DE602005020112D1 - Derivate von pyridin und chinolin - Google Patents
Derivate von pyridin und chinolinInfo
- Publication number
- DE602005020112D1 DE602005020112D1 DE602005020112T DE602005020112T DE602005020112D1 DE 602005020112 D1 DE602005020112 D1 DE 602005020112D1 DE 602005020112 T DE602005020112 T DE 602005020112T DE 602005020112 T DE602005020112 T DE 602005020112T DE 602005020112 D1 DE602005020112 D1 DE 602005020112D1
- Authority
- DE
- Germany
- Prior art keywords
- chinoline
- pyridine
- derivatives
- blocking
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Pyridine Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200400072A ES2237332B1 (es) | 2004-01-14 | 2004-01-14 | Derivados de piridinio y quinolinio. |
PCT/ES2005/070002 WO2005068429A1 (es) | 2004-01-14 | 2005-01-11 | Derivados de piridinio y quinolinio |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005020112D1 true DE602005020112D1 (de) | 2010-05-06 |
Family
ID=34778265
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005020112T Active DE602005020112D1 (de) | 2004-01-14 | 2005-01-11 | Derivate von pyridin und chinolin |
Country Status (16)
Country | Link |
---|---|
US (1) | US7781458B2 (de) |
EP (2) | EP1710236B1 (de) |
JP (2) | JP5047627B2 (de) |
KR (1) | KR101157206B1 (de) |
CN (1) | CN1910153B (de) |
AT (1) | ATE461918T1 (de) |
BR (1) | BRPI0506486A (de) |
CA (1) | CA2553328C (de) |
DE (1) | DE602005020112D1 (de) |
DK (1) | DK1710236T3 (de) |
ES (2) | ES2237332B1 (de) |
HK (1) | HK1100441A1 (de) |
MX (1) | MXPA06007940A (de) |
PL (1) | PL1710236T3 (de) |
PT (1) | PT1710236E (de) |
WO (1) | WO2005068429A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8586613B2 (en) * | 2004-01-14 | 2013-11-19 | Universidad De Granada | Pyridinium and quinolinium derivatives |
MX2011000147A (es) | 2008-07-04 | 2011-05-24 | Traslational Cancer Drugs Pharma S L | Metodos para el tratamiento y diagnostico del cancer. |
US20100068302A1 (en) * | 2008-09-17 | 2010-03-18 | Traslational Cancer Drugs Pharma, S.L. | Methods and compositions for the treatment of cancer |
US20110212994A1 (en) * | 2009-06-26 | 2011-09-01 | Brian Clem | Small Molecule Choline Kinase Inhibitors, Screening Assays, and Methods for Safe and Effective Treatment of Neoplastic Disorders |
WO2012041493A1 (en) * | 2010-09-28 | 2012-04-05 | Julius-Maximilians-Universität Würzburg | Aminoquinolinium salts, methods of their production and their use as active agents for biotechnological and medical applications against binary toxins |
EP2468259A1 (de) * | 2010-12-23 | 2012-06-27 | Traslational Cancer Drugs Pharma, S.L. | Pharmazeutische Zusammensetzungen aus Pyridinium- und Chinoliniumderivaten |
EP2721174A1 (de) | 2011-06-20 | 2014-04-23 | Traslational Cancer Drugs Pharma, S.L. | Verfahren zur vorhersage des klinischen ansprechens auf eine chemotherapie bei einem probanden mit krebs |
US20130281445A1 (en) * | 2011-09-22 | 2013-10-24 | Simon Everitt | Compounds useful as inhibitors of choline kinase |
ES2472367B1 (es) * | 2012-12-28 | 2015-06-02 | Universidad De Granada | Inhibidores no simétricos de colina quinasa con actividad antitumoral y antimalárica |
WO2015028662A1 (en) | 2013-08-30 | 2015-03-05 | Consejo Superior De Investigaciones Cientificas (Csic) | Compositions and methods for characterization and amelioration of rheumatoid arthritis |
ES2482290B1 (es) * | 2014-06-05 | 2015-05-19 | Universidad De Granada | Inhibidores polares simétricos de colina cinasa con actividad antitumoral |
CN109790164B (zh) | 2016-07-25 | 2022-01-25 | 内尔维亚诺医疗科学公司 | 作为胆碱激酶抑制剂的嘌呤和3-去氮杂嘌呤类似物 |
EP3652177A1 (de) | 2017-07-11 | 2020-05-20 | Nerviano Medical Sciences S.r.l. | Pyrazolchinazolinderivate als cholinkinaseinhibitoren |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1533952A (en) * | 1976-02-25 | 1978-11-29 | Sterling Drug Inc | Anti-microbial bis-pyridinium compounds |
US4206215A (en) * | 1976-02-25 | 1980-06-03 | Sterling Drug Inc. | Antimicrobial bis-[4-(substituted-amino)-1-pyridinium]alkanes |
FR2498187A1 (fr) * | 1981-01-16 | 1982-07-23 | Rhone Poulenc Sante | Procede de preparation d'amino-4 chloro-7 quinoleines |
GT198900005A (es) * | 1988-01-29 | 1990-07-17 | Quinolinas y cinolinas substituidas. | |
ES2117950B1 (es) * | 1996-08-02 | 1999-09-16 | Univ Granada | Nuevos compuestos que bloquean la biosintesis de fosforilcolina y su uso como segundo mensajero en proliferacion celular. |
-
2004
- 2004-01-14 ES ES200400072A patent/ES2237332B1/es not_active Expired - Fee Related
-
2005
- 2005-01-11 EP EP05708100A patent/EP1710236B1/de active Active
- 2005-01-11 CA CA2553328A patent/CA2553328C/en not_active Expired - Fee Related
- 2005-01-11 JP JP2006548321A patent/JP5047627B2/ja not_active Expired - Fee Related
- 2005-01-11 MX MXPA06007940A patent/MXPA06007940A/es active IP Right Grant
- 2005-01-11 BR BRPI0506486-4A patent/BRPI0506486A/pt not_active IP Right Cessation
- 2005-01-11 PT PT05708100T patent/PT1710236E/pt unknown
- 2005-01-11 KR KR1020067016298A patent/KR101157206B1/ko not_active IP Right Cessation
- 2005-01-11 CN CN2005800024289A patent/CN1910153B/zh not_active Expired - Fee Related
- 2005-01-11 US US10/597,095 patent/US7781458B2/en not_active Expired - Fee Related
- 2005-01-11 DK DK05708100.2T patent/DK1710236T3/da active
- 2005-01-11 ES ES05708100T patent/ES2343418T3/es active Active
- 2005-01-11 PL PL05708100T patent/PL1710236T3/pl unknown
- 2005-01-11 AT AT05708100T patent/ATE461918T1/de active
- 2005-01-11 WO PCT/ES2005/070002 patent/WO2005068429A1/es active Application Filing
- 2005-01-11 DE DE602005020112T patent/DE602005020112D1/de active Active
- 2005-01-11 EP EP09157208A patent/EP2085386A3/de not_active Withdrawn
-
2007
- 2007-07-31 HK HK07108357.3A patent/HK1100441A1/xx not_active IP Right Cessation
-
2012
- 2012-03-19 JP JP2012062569A patent/JP5619805B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
BRPI0506486A (pt) | 2007-02-13 |
EP2085386A2 (de) | 2009-08-05 |
ATE461918T1 (de) | 2010-04-15 |
EP2085386A3 (de) | 2009-10-28 |
KR101157206B1 (ko) | 2012-07-06 |
JP5047627B2 (ja) | 2012-10-10 |
EP1710236A1 (de) | 2006-10-11 |
US20070185170A1 (en) | 2007-08-09 |
ES2237332A1 (es) | 2005-07-16 |
US7781458B2 (en) | 2010-08-24 |
PT1710236E (pt) | 2010-06-18 |
DK1710236T3 (da) | 2010-07-12 |
EP1710236B1 (de) | 2010-03-24 |
CN1910153B (zh) | 2010-05-26 |
ES2343418T3 (es) | 2010-07-30 |
JP5619805B2 (ja) | 2014-11-05 |
CA2553328A1 (en) | 2005-07-28 |
KR20060110364A (ko) | 2006-10-24 |
CN1910153A (zh) | 2007-02-07 |
CA2553328C (en) | 2012-05-15 |
ES2237332B1 (es) | 2006-11-01 |
HK1100441A1 (en) | 2007-09-21 |
WO2005068429A1 (es) | 2005-07-28 |
MXPA06007940A (es) | 2007-01-23 |
JP2007517837A (ja) | 2007-07-05 |
PL1710236T3 (pl) | 2010-08-31 |
JP2012149077A (ja) | 2012-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005020112D1 (de) | Derivate von pyridin und chinolin | |
CY1121202T1 (el) | ΠΑΡΑΓΩΓΑ ΠΥΡΡΟΛΟ[2,3-b)]ΠΥΡΙΜΙΔΙΝΗΣ ΩΣ ΑΝΑΣΤΟΛΕΑΣ ΚΙΝΑΣΗΣ JANUS | |
ATE447559T1 (de) | 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3- carboxamid derivate als mek inhibitoren zur behandlung von hyperproliferativen erkrankungen | |
ATE432260T1 (de) | Pyridinderivate als pkc-theta-hemmer | |
ATE316077T1 (de) | Pyrimidin-essigsäure derivate geeignet zur behandlung von crth2-bedingten krankheiten | |
BRPI0506736A (pt) | composto estereoisoméricos e métodos para o tratamento de distúrbios gastrointestinais e no sistema nervoso central | |
CY1112402T1 (el) | Ενισχυτες υποδοχεων γλουταμικου | |
DE50310516D1 (de) | Fredericamycin-derivate | |
DK1519724T3 (da) | Fredericamycin-derivater som lægemidler til behandling af tumorer | |
CY1111083T1 (el) | Παραγωγα νικοτιναμιδιου χρησιμα ως αναστολεις της p38 | |
DE602005017626D1 (de) | Antivirale verwendung von borinsäurekomplexen | |
NO20071843L (no) | Substituerte anilinderivater | |
ATE384061T1 (de) | Imidazo- und thiazolopyridine als jak3-kinase- inhibitoren | |
EA200801775A1 (ru) | Пиридин-4-илметиламиды для борьбы с вредителями | |
BRPI0608216A2 (pt) | agente terapêutico para um tumor, método para tratar um tumor, e, uso de um composto de benzoìla, uma pró-groga do mesmo ou um sal farmaceuticamente aceitável do mesmo | |
ATE532789T1 (de) | Dihydrothienopyrimidine als akt-proteinkinase- inhibitoren | |
CY1115690T1 (el) | Συνθεσεις βασιζομενες σε arthrospirα και χρησεις αυτων | |
ATE543803T1 (de) | 3-ä2-(3-azylamino-2-oxo-2h-pyridin-1- yl)acetylaminoü-4-oxopentansäurederivate und deren verwendung als caspase-inhibitoren | |
BR0310055A (pt) | Derivados de piridinacarboxamida pesticidas | |
ATE488510T1 (de) | Heterocyclische derivate, deren herstellung und therapeutische verwendung | |
NO20054631D0 (no) | Antistoff mot tumorspesifikt antigen som mal | |
EA201590074A1 (ru) | Производное бензодиоксола, способ его получения и его применение | |
DE602004021358D1 (de) | Benzosulfonamide derivate, deren verfahren zum herstellung, und deren verwendung zur behandlung von schmerzen | |
FR2894579B1 (fr) | Derives diaryltriazolmethylamine, leur preparation et leur application en therapeutique. | |
BRPI0507745A (pt) | compostos de azetidina substituìda como inibidores de ciclooxigenase-1-ciclooxigenase-2, processo para a sua preparação, medicamentos e seus usos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |